Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.894
-0.006 (-0.67%)
Dec 27, 2024, 4:00 PM EST - Market closed
Acurx Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 27, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 15 | 53 | 46 | 44 | - | - |
| Market Cap Growth | 58.22% | 14.29% | 4.51% | - | - | - |
| Enterprise Value | 9 | 46 | 36 | 30 | - | - |
| Last Close Price | 0.89 | 3.83 | 3.98 | 4.32 | - | - |
| PB Ratio | 5.63 | 11.30 | 6.31 | 3.56 | - | - |
| P/TBV Ratio | 11.59 | 11.30 | 6.31 | 3.56 | - | - |
| Debt / Equity Ratio | - | - | - | - | 0.02 | - |
| Quick Ratio | 1.77 | 2.50 | 4.42 | 15.36 | 6.72 | 1.45 |
| Current Ratio | 1.80 | 2.53 | 4.55 | 15.71 | 6.82 | 1.48 |
| Return on Equity (ROE) | -498.16% | -243.33% | -122.61% | -168.71% | -261.26% | - |
| Return on Assets (ROA) | -156.34% | -106.65% | -66.79% | -97.21% | -99.91% | - |
| Return on Capital (ROIC) | -311.35% | -152.08% | -76.63% | -105.53% | -160.26% | - |
| Earnings Yield | -108.83% | -27.65% | -26.21% | -28.88% | - | - |
| FCF Yield | -81.65% | -18.59% | -16.35% | -11.36% | - | - |
| Buyback Yield / Dilution | -27.05% | -17.15% | -26.72% | -37.88% | -30.29% | - |
| Total Shareholder Return | -27.05% | -17.15% | -26.72% | -37.88% | -30.29% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.